Prof. Alireza Heidari
Faculty of
Chemistry
California South
University (CSU), Irvine, California, USA
Emails: Scholar.Researcher.Scientist@gmail.com(preferred), Alireza.Heidari@calsu.us
Qualifications
2012, Ph.D., Faculty
of Chemistry, California South University (CSU), Irvine, California, USA
2008, M.S., Faculty
of Chemistry, Islamic Azad University (IAU), North Tehran Branch, Tehran, Iran
2005, B.S., Faculty
of Chemistry, Islamic Azad University (IAU), North Tehran Branch, Tehran, Iran
Publications (selected)
-
A. Heidari, C.
Brown, “Study of Composition and Morphology of Cadmium Oxide (CdO)
Nanoparticles for Eliminating Cancer Cells”, Journal of Nanomedicine
Research, Volume 2, Issue 5, 20 Pages, 2015.
-
A. Heidari, C. Brown, “Study of Surface Morphological, Phytochemical and
Structural Characteristics of Rhodium (III) Oxide (Rh2O3)
Nanoparticles”, International Journal of Pharmacology, Phytochemistry and
Ethnomedicine, Volume 1, Pages 15–19, 2015.
-
A. Heidari, “Computational
Studies on Molecular Structures and Carbonyl and Ketene Groups’ Effects of
Singlet and Triplet Energies of Azidoketene O=C=CH–NNN and Isocyanatoketene
O=C=CH–N=C=O”, J Appl Computat Math 5: e142, 2016.
-
A. Heidari, “Study
of Irradiations to Enhance the Induces the Dissociation of Hydrogen Bonds
between Peptide Chains and Transition from Helix Structure to Random Coil
Structure Using ATR–FTIR, Raman and 1HNMR Spectroscopies”, J
Biomol Res Ther 5: e146, 2016.
-
A. Heidari, “Future
Prospects of Point Fluorescence Spectroscopy, Fluorescence Imaging and
Fluorescence Endoscopy in Photodynamic Therapy (PDT) for Cancer Cells”, J
Bioanal Biomed 8: e135, 2016.
-
A. Heidari, “Quantitative
Structure–Activity Relationship (QSAR) Approximation for Cadmium Oxide (CdO)
and Rhodium (III) Oxide (Rh2O3) Nanoparticles as
Anti–Cancer Drugs for the Catalytic Formation of Proviral DNA from Viral RNA
Using Multiple Linear and Non–Linear Correlation Approach”, Ann Clin Lab
Res. 4: 1, 2016.
-
A. Heidari, “Spectroscopy
and Quantum Mechanics of the Helium Dimer (He2+), Neon Dimer (Ne2+),
Argon Dimer (Ar2+), Krypton Dimer (Kr2+), Xenon Dimer (Xe2+),
Radon Dimer(Rn2+) and Ununoctium Dimer (Uuo2+) Molecular
Cations”, Chem Sci J 7: e112, 2016.
-
A. Heidari, “A
Combined Computational and QM/MM Molecular Dynamics Study on Boron Nitride
Nanotubes (BNNTs), Amorphous Boron Nitride Nanotubes (a–BNNTs) and Hexagonal
Boron Nitride Nanotubes (h–BNNTs) as Hydrogen Storage”, Struct Chem
Crystallogr Commun 2: 1, 2016.
-
A. Heidari, “Combined
Theoretical and Computational Study of the Belousov–Zhabotinsky Chaotic
Reaction and Curtius Rearrangement for Synthesis of Mechlorethamine, Cisplatin,
Streptozotocin, Cyclophosphamide, Melphalan, Busulphan and BCNU as Anti–Cancer
Drugs”, Insights Med Phys. 1: 2, 2016.
-
A. Heidari, “Ab
Initio and Density Functional Theory (DFT) Studies of Dynamic NMR Shielding
Tensors and Vibrational Frequencies of DNA/RNA and Cadmium Oxide (CdO)
Nanoparticles Complexes in Human Cancer Cells”, J Nanomedine Biotherapeutic
Discov 6: e144, 2016.
-
A. Heidari, “Molecular
Dynamics and Monte–Carlo Simulations for Replacement Sugars in Insulin
Resistance, Obesity, LDL Cholesterol, Triglycerides, Metabolic Syndrome, Type 2
Diabetes and Cardiovascular Disease: A Glycobiological Study”, J Glycobiol
5: e111, 2016.
-
A. Heidari, “Nitrogen,
Oxygen, Phosphorus and Sulphur Heterocyclic Anti–Cancer Nano Drugs Separation
in the Supercritical Fluid of Ozone (O3) Using Soave–Redlich–Kwong
(SRK) and Pang–Robinson (PR) Equations”, Electronic J Biol 12: 4, 2016.
-
A. Heidari, “An
Analytical and Computational Infrared Spectroscopic Review of Vibrational Modes
in Nucleic Acids”, Austin J Anal Pharm Chem. 3(1): 1058, 2016.
-
A. Heidari, C.
Brown, “Phase, Composition and Morphology Study and Analysis of Os–Pd/HfC
Nanocomposites”, Nano Res Appl. 2: 1, 2016.
-
A. Heidari, C.
Brown, “Vibrational Spectroscopic Study of Intensities and Shifts of
Symmetric Vibration Modes of Ozone Diluted by Cumene”, International
Journal of Advanced Chemistry, 4 (1) 5–9, 2016.
-
A. Heidari, “Linear
and Non–Linear Quantitative Structure–Anti–Cancer–Activity Relationship
(QSACAR) Study of Hydrous Ruthenium (IV) Oxide (RuO2) Nanoparticles
as Non–Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) and Anti–Cancer
Nano Drugs”, J Integr Oncol 5: e110, 2016.
-
A. Heidari, “A
Pharmacovigilance Study on Linear and Non–Linear Quantitative Structure
(Chromatographic) Retention Relationships (QSRR) Models for the Prediction of
Retention Time of Anti–Cancer Nano Drugs under Synchrotron Radiations”, J
Pharmacovigil 4: e161, 2016.
-
A. Heidari, “A
Gastrointestinal Study on Linear and Non–Linear Quantitative Structure
(Chromatographic) Retention Relationships (QSRR) Models for Analysis
5–Aminosalicylates Nano Particles as Digestive System Nano Drugs under
Synchrotron Radiations”, J Gastrointest Dig Syst 6: e119, 2016.
-
A. Heidari, “A Successful Strategy for the Prediction of Solubility in the
Construction of Quantitative Structure–Activity Relationship (QSAR) and
Quantitative Structure–Property Relationship (QSPR) under Synchrotron
Radiations Using Genetic Function Approximation (GFA) Algorithm”,
J Mol Biol Biotechnol 1: 1, 2016.
-
A. Heidari, “Computational
Study on Molecular Structures of C20, C60, C240,
C540, C960, C2160 and C3840 Fullerene Nano Molecules under Synchrotron Radiations Using Fuzzy Logic”, J
Material Sci Eng 5: 282, 2016.
-
A. Heidari, “Graph
Theoretical Analysis of Zigzag Polyhexamethylene Biguanide, Polyhexamethylene
Adipamide, Polyhexamethylene Biguanide Gauze and Polyhexamethylene Biguanide
Hydrochloride (PHMB) Boron Nitride Nanotubes (BNNTs), Amorphous Boron Nitride
Nanotubes (a–BNNTs) and Hexagonal Boron Nitride Nanotubes (h–BNNTs)”, J
Appl Computat Math 5: e143, 2016.
-
A. Heidari, “Yoctosecond
Quantitative Structure–Activity Relationship (QSAR) and Quantitative
Structure–Property Relationship (QSPR) under Synchrotron Radiations Studies
for Prediction of Solubility of Anti–Cancer Nano Drugs in Aqueous Solutions
Using Genetic Function Approximation (GFA) Algorithm”, Insight Pharm Res.
1: 1, 2016.
-
A. Heidari, “Polymorphism in Nano–Sized Graphene Ligand–Induced Transformation
of Au38–xAgx/xCux(SPh–tBu)24 to Au36–xAgx/xCux(SPh–tBu)24 (x
= 1–12) Nanomolecules for Synthesis of Au144–xAgx/xCux[(SR)60,
(SC4)60, (SC6)60, (SC12)60,
(PET)60, (p–MBA)60, (F)60, (Cl)60,
(Br)60, (I)60, (At)60, (Uus)60 and
(SC6H13)60] Nano Clusters as Anti–Cancer Nano
Drugs”, J Nanomater Mol Nanotechnol, 6: 3, 2017.
-
A. Heidari, “Study of Synthesis, Pharmacokinetics, Pharmacodynamics, Dosing, Stability, Safety and Efficacy of Olympiadane Nanomolecules as Agent for Cancer Enzymotherapy, Immunotherapy, Chemotherapy, Radiotherapy, Hormone Therapy and Targeted Therapy under Synchrotorn Radiation”, J Dev
Drugs 6: e154.
-
A. Heidari, “Concurrent Diagnosis of Oncology Influence Outcomes in Emergency
General Surgery for Colorectal Cancer and Multiple Sclerosis(MS)
Treatment Using Magnetic Resonance Imaging (MRI) and Au329(SR)84,
Au329–xAgx(SR)84, Au144(SR)60, Au68(SR)36, Au30(SR)18,
Au102(SPh)44, Au38(SPh)24, Au38(SC2H4Ph)24,
Au21S(SAdm)15, Au36(pMBA)24 and Au25(pMBA)18 Nano Clusters”, J Surgery
Emerg Med 1: 21, 2017.
Profile Details
http://calsu.us/index.php/member/prof-dr-alireza-heidari/